AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
agilon health Inc (NYSE:AGL)
95.23 USD
+12.530 15.151%Sponsored Reports
Loading...
| Previous Close (in USD) | 82.7 |
|---|---|
| Change | +12.530 15.151% |
| 52 W H/L (in USD) | 119.500/7.480 |
| EBITDA (in USD) | -406.182M |
| PE Ratio | -- |
| Volume | 304952 |
| Diluted Eps TTM | -24.50 |
| Total Assets (in USD) | 1271.29M |
|---|---|
| Total Liabilities (in USD) | 1144.556M |
| Revenue TTM (in USD) | 5932.576M |
| Cash (in USD) | 173.713M |
| Market Cap (in USD) | 469.950 M |
| Revenue Per Share TTM | 358.274 |
| Gross Profit TTM (in USD) | -160.021M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
agilon health Inc
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
440 Polaris Parkway, Westerville, OH, United States, 43082
562 256 3800
Employees: 856
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Steven Jackson Sell | Pres, CEO & Director | 1966 |
| 2. | Mr. Timothy S. Bensley | Chief Financial Officer | 1960 |
| 3. | Mr. Girish Venkatachaliah | Chief Technology Officer | 1974 |
| 4. | Mr. Ben Shaker | Chief Markets Officer | 1983 |
| 5. | Mr. Veeral Desai | Chief Strategy & Devel. Officer | 1981 |
| 6. | Ms. Priscilla Kasenchak | Chief Accounting Officer | 1981 |
| 7. | Mr. Matthew Dale Gillmor CFA | VP of Investor Relations | NA |
| 8. | Ms. Denise Zamore | Chief Legal Officer & Sec. | NA |
| 9. | Ms. Claire Mulhearn | Chief Communications & Public Affairs Officer | NA |
| 10. | Mr. Mat Varghese | Chief People Officer | NA |
Peers
Sector: Healthcare
Industry: Medical Care Facilities
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
HCA
HCA Healthcare, Inc. |
-1.400 0.385% | 365.3 | 13.190 | 13.661 | 1.132 | 293.440 | 1.769 | 8.216 |
|
FSNUY
Fresenius SE & Co KGaA ADR |
+0.220 2.095% | 10.7 | 16.870 | 9.443 | 0.421 | 0.775 | 0.789 | 5.371 |
|
JDHIY
JD Health International Inc |
0.000 0.000% | 5.2 | 62.500 | 35.971 | 0.297 | 2.321 | 0.157 | 3.898 |
|
JDHIF
JD Health International Inc |
0.000 0.000% | 5.9 | 57.750 | 32.680 | 0.289 | 2.108 | 0.157 | 3.898 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Income Before Tax | -404.096M | -248.826M | -194.462M | -105.689M | -404.598M |
| Minority Interest | 0M | -0.05M | 0.239M | -0.311M | -0.3M |
| Net Income | -405.347M | -260.151M | -262.596M | -106.864M | -405.484M |
| Selling General Administrative | 238.536M | 268.912M | 285.76M | 218.945M | 455.821M |
| Gross Profit | -188.615M | 4.841M | 69.67M | 112.286M | 76.413M |
| Reconciled Depreciation | 28.594M | 24.463M | 18.921M | 13.772M | 14.67M |
| Ebit | -397.455M | -242.649M | -187.804M | -110.214M | -393.952M |
| Ebitda | -368.861M | -218.186M | -167.643M | -96.442M | -383.782M |
| Depreciation And Amortization | 28.594M | 24.463M | 20.161M | 13.772M | 10.17M |
| Operating Income | -421.076M | -292.13M | -232.133M | -110.214M | -393.952M |
| Other Operating Expenses | 6353.652M | 6352.66M | 4548.496M | 218.945M | 2227.511M |
| Interest Expense | 6.641M | 6.177M | 6.658M | 4.525M | 6.146M |
| Tax Provision | 1.251M | 1.451M | 1.096M | 1.64M | 0.886M |
| Interest Income | 8.476M | 8.815M | 9.831M | 4.525M | 6.146M |
| Net Interest Income | -6.641M | -6.177M | -6.481M | -4.525M | -6.146M |
| Income Tax Expense | 1.251M | 1.451M | 0.791M | 1.175M | 0.886M |
| Total Revenue | 5932.576M | 6060.53M | 4316.363M | 2708.211M | 1833.559M |
| Total Operating Expenses | 232.461M | 296.971M | 301.803M | 218.945M | 470.365M |
| Cost Of Revenue | 6121.191M | 6055.689M | 4246.693M | 2595.925M | 1757.146M |
| Total Other Income Expense Net | 16.98M | 43.304M | 37.671M | 4.525M | -10.646M |
| Net Income From Continuing Ops | -405.347M | -250.277M | -88.833M | -107.329M | -405.484M |
| Net Income Applicable To Common Shares | -391.347M | -260.151M | -262.596M | -106.553M | -406.487M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Total Assets | 1271.29M | 1733.983M | 1740.866M | 1697.468M | 1586.252M |
| Intangible Assets | 65.725M | 72.771M | 63.769M | 67.68M | 55.398M |
| Other Current Assets | 137.762M | 35.137M | 49.272M | 34.119M | 33.749M |
| Total Liab | 1144.556M | 1263.031M | 1079.845M | 656.859M | 494.656M |
| Total Stockholder Equity | 126.734M | 470.952M | 661.839M | 1041.22M | 1091.896M |
| Other Current Liab | 1057.247M | -2.46M | 968.06M | 346.727M | 351.96M |
| Common Stock | 4.147M | 4.122M | 4.064M | 4.124M | 4.001M |
| Capital Stock | 4.147M | 4.122M | 4.064M | 4.124M | 4.001M |
| Retained Earnings | -1978.324M | -1586.977M | -1326.826M | -1064.23M | -957.677M |
| Good Will | 0M | 24.133M | 24.133M | 41.54M | 41.54M |
| Other Assets | 20.122M | 80.597M | 0M | 86.543M | 225.916M |
| Cash | 173.713M | 193.86M | 107.57M | 497.07M | 1040.039M |
| Cash And Equivalents | 173.713M | 188.231M | - | 497.07M | 1040.039M |
| Total Current Liabilities | 1076.485M | 1152.006M | 977.156M | 535.091M | 356.96M |
| Current Deferred Revenue | - | - | -970.906M | -346.727M | -351.96M |
| Net Debt | -136.898M | -149.897M | -55.261M | -453.588M | -991.638M |
| Short Term Debt | 19.238M | 2.46M | 9.096M | 5M | 5M |
| Short Long Term Debt | 19.238M | - | 6.25M | 5M | 5M |
| Short Long Term Debt Total | 36.815M | 43.963M | 52.309M | 43.482M | 48.401M |
| Other Stockholder Equity | 2099.995M | 2053.895M | 1986.899M | 2106.886M | 2045.572M |
| Property Plant Equipment | 28.959M | 36.952M | - | 20.05M | 9.161M |
| Total Current Assets | 1096.697M | 1457.774M | 1480.076M | 1451.274M | 1367.195M |
| Long Term Investments | 59.787M | 61.756M | 44.753M | 17.352M | 6.69M |
| Short Term Investments | 111.429M | 211.737M | 380.773M | 411.901M | - |
| Net Receivables | 673.793M | 1017.04M | 942.461M | 497.574M | 293.407M |
| Long Term Debt | 15.75M | 34.904M | 32.308M | 38.482M | 43.401M |
| Inventory | - | - | -42.513M | 10.61M | - |
| Accounts Payable | 1057.247M | 1149.546M | 968.06M | 530.091M | 351.96M |
| Accumulated Other Comprehensive Income | 0.916M | -0.088M | -2.298M | -5.56M | - |
| Non Currrent Assets Other | 23.664M | 80.597M | 87.148M | 116.924M | 112.958M |
| Non Current Assets Total | 174.593M | 276.209M | 260.79M | 246.194M | 219.057M |
| Capital Lease Obligations | 1.827M | 6.599M | 10.905M | 9.885M | 7.904M |
| Long Term Debt Total | 15.75M | 34.904M | - | 38.482M | 43.401M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Investments | 133.718M | 139.891M | -49.786M | -412.227M | -75.736M |
| Total Cashflows From Investing Activities | 88.61M | 139.891M | -44.019M | -444.388M | -90.506M |
| Total Cash From Financing Activities | -2.994M | -2.583M | -193.133M | 28.056M | 1154.39M |
| Net Income | -391.347M | -260.101M | -262.803M | -106.864M | -406.787M |
| Change In Cash | -20.147M | 79.531M | -393.351M | -547.14M | 915.725M |
| Begin Period Cash Flow | 193.86M | 114.329M | 507.68M | 1054.82M | 139.095M |
| End Period Cash Flow | 173.713M | 193.86M | 114.329M | 507.68M | 1054.82M |
| Total Cash From Operating Activities | -105.763M | -57.777M | -156.199M | -130.808M | -148.159M |
| Depreciation | 28.594M | 24.463M | 20.161M | 13.772M | 14.67M |
| Other Cashflows From Investing Activities | -31.866M | -41.767M | -34.513M | -16.735M | -8.206M |
| Dividends Paid | - | - | 6.867M | - | - |
| Change To Inventory | - | - | - | - | - |
| Sale Purchase Of Stock | -2.994M | 1.167M | -200M | 33.056M | 1189.028M |
| Other Cashflows From Financing Activities | -2.994M | -3.75M | -44.019M | -444.388M | 103.347M |
| Capital Expenditures | 13.242M | 13.251M | 30.815M | 32.661M | 13.426M |
| Change In Working Capital | 189.469M | 130.589M | -10.067M | -59.435M | -55.025M |
| Other Non Cash Items | 18.402M | -3.385M | 27.184M | -7.194M | 9.82M |
| Free Cash Flow | -119.005M | -71.028M | -187.014M | -163.469M | -161.585M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BrighthouseI Morgan Stanley Discovery B | 5 months ago | 8222166 |
| 2. | Morgan Stanley Insight | 5 months ago | 8046130 |
| 3. | Morgan Stanley Insight I | 5 months ago | 8046130 |
| 4. | Capital Group World Growth & Inc Cmp | 5 months ago | 8007033 |
| 5. | Morgan Stanley Discovery | 5 months ago | 5946985 |
| 6. | Morgan Stanley Inst Discovery I | 5 months ago | 5946985 |
| 7. | Schwab Fundamental U.S. Small CompanyETF | 2 months ago | 5083480 |
| 8. | Morgan Stanley Inst Inception I | 5 months ago | 4505540 |
| 9. | Morgan Stanley Inception | 5 months ago | 4505540 |
| 10. | EQ/Morgan Stanley Small Cap Growth K | 3 months ago | 3273179 |
| 11. | Fidelity Small Cap Index | 4 months ago | 2988746 |
| 12. | MS INVF Global Insight Z | 5 months ago | 2204787 |
| 13. | Russell 2000 Equity Index Fund B | 5 months ago | 2016978 |
| 14. | Schwab US Small-Cap ETF™ | 2 months ago | 1554180 |
| 15. | Vanguard Growth & Income Inv | 5 months ago | 1454900 |
| 16. | Morgan Stanley VIF Discovery I | 5 months ago | 1269583 |
| 17. | State St Russell Sm Cap® Indx SL Cl I | 3 months ago | 1102300 |
| 18. | Strategic Advisers U.S. Total Stock | 3 months ago | 1055800 |
| 19. | Extended Equity Market Fund B | 5 months ago | 802059 |
| 20. | Extended Equity Market Fund E | 5 months ago | 802059 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Clayton Dubilier & Rice LLC | 5 months ago | 100000000 |
| 2. | Morgan Stanley - Brokerage Accounts | 8 months ago | 59384795 |
| 3. | North Peak Capital Management, LLC | 5 months ago | 38139937 |
| 4. | BlackRock Inc | 8 months ago | 24197634 |
| 5. | D. E. Shaw & Co LP | 5 months ago | 20311334 |
| 6. | The Goldman Sachs Group Inc | 5 months ago | 20055214 |
| 7. | Vanguard Group Inc | 5 months ago | 18321808 |
| 8. | AQR Capital Management LLC | 5 months ago | 10211767 |
| 9. | Capital World Investors | 5 months ago | 8364227 |
| 10. | Charles Schwab Investment Management Inc | 5 months ago | 8019002 |
| 11. | State Street Corp | 8 months ago | 7707516 |
| 12. | Geode Capital Management, LLC | 5 months ago | 7177477 |
| 13. | CenterBook Partners LP | 5 months ago | 7021522 |
| 14. | Rock Springs Capital Management LP | 5 months ago | 6500000 |
| 15. | Bank of America Corp | 8 months ago | 5414614 |
| 16. | JPMorgan Chase & Co | 8 months ago | 4210594 |
| 17. | Jacobs Levy Equity Management, Inc. | 5 months ago | 4037979 |
| 18. | FMR Inc | 5 months ago | 2882933 |
| 19. | Northern Trust Corp | 8 months ago | 2649258 |
| 20. | Renaissance Technologies Corp | 5 months ago | 2371037 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...